Romosozumab Clinical Trials
7 recruitingDrug
Phase 44Phase 32
Showing 1–7 of 7 trials
Recruiting
Sequential Therapies After Osteoanabolic Treatment
Osteoporosis, Postmenopausal
424 General Military Hospital150 enrolled8 locationsNCT06164795
Recruiting
Phase 4
The Optimised Use of Romozosumab Study
Osteoporosis
University of Aarhus270 enrolled1 locationNCT06059222
Recruiting
Phase 3
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
Osteogenesis Imperfecta
Amgen106 enrolled65 locationsNCT05972551
Recruiting
Phase 3
Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea
FHA (Functional Hypothalamic Amenorrhea)
Massachusetts General Hospital114 enrolled2 locationsNCT06533865
Recruiting
Phase 4
Combined Anabolic Therapy
OsteoporosisOsteoporosis, Postmenopausal
Massachusetts General Hospital50 enrolled1 locationNCT06558188
Recruiting
Phase 4
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
Osteoporosis
National Taiwan University Hospital90 enrolled1 locationNCT07283887
Recruiting
Phase 4
Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study
OsteoporosisGlucocorticoids Toxicity
Tuen Mun Hospital63 enrolled1 locationNCT06472050